FORA Capital’s Sabra Healthcare REIT SBRA Stock Holding History

FORA Capital’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,950	Closed	-$199K	–	779
2021 Q2	$199K	Buy	+10,950	New	+$195K	0.04%	441

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAMU

APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FORA Capital's SBRA Position: Q3 2021 in Review

FORA Capital sold out of Sabra Healthcare REIT (SBRA) in Q3 2021, closing a stake of 10,950 shares — an estimated $199K sold.

FORA Capital first reported a position in SBRA in Q2 2021 and held it in 1 quarter. The position peaked at $199K in Q2 2021. 326 funds tracked by Wall St. Rank hold SBRA as of Q3 2021.

FORA Capital reported no remaining Sabra Healthcare REIT position as of Q3 2021 after selling out during the quarter.
FORA Capital sold 10,950 Sabra Healthcare REIT shares in Q3 2021, an estimated $199K.
FORA Capital first reported a position in Sabra Healthcare REIT in Q2 2021 and held it in 1 quarter.
FORA Capital's Sabra Healthcare REIT position peaked at $199K in Q2 2021.
326 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2021.

Based on FORA Capital's 13F filing for Q3 2021, filed 15 Nov 2021.